| Literature DB >> 36134084 |
Derrick Huang1, Shane Dluzneski1, Michael Hughes1, Samyr Elbadri1, Latha Ganti2,3,4.
Abstract
Rhabdomyolysis secondary to prescription drug-drug interactions can be an overlooked life-threatening emergency. Amphetamines and similar substances have been associated with muscle lysis secondary to increased sympathetic activity that can cause myotoxicity, hyperthermia, and increased muscular activity. Anabolic steroids may also be a predisposing factor in developing rhabdomyolysis. A high index of suspicion for drug-induced rhabdomyolysis in a patient presenting with atraumatic extremity pain can facilitate rapid diagnosis and treatment. We present a case of drug-induced rhabdomyolysis likely secondary to a previously unreported medication interaction.Entities:
Keywords: amphetamine-dextroamphetamine; aromatase inhibitor; attention deficit hyperactivity disorder (adhd); dexmethylphenidate; growth hormone replacement therapy; letrozole; non-traumatic rhabdomyolysis; pituitary hormone replacement
Year: 2022 PMID: 36134084 PMCID: PMC9470210 DOI: 10.7759/cureus.27988
Source DB: PubMed Journal: Cureus ISSN: 2168-8184